Condensed Consolidated Statements of Comprehensive Profit (Unaudited) - USD ($) |
3 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Oct. 01, 2025 |
Dec. 31, 2024 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Income: | ||||
| Mark to Market Gain/(Loss) | $ (24) | $ (859) | ||
| Realized Gain – Private Investments | 11,663 | |||
| Mark to Market Private Equity | (245,464) | (245,464) | ||
| Dividend Income | $ 116,510 | $ 116,510 | 75,687 | |
| Total Income | 116,510 | (245,488) | 116,510 | (158,973) |
| Operating expenses: | ||||
| Compensation – stock options | 16,682 | 41,070 | 66,183 | 145,248 |
| Professional fees | 4,042 | 8,808 | 8,174 | 15,346 |
| State and local taxes | 492 | 12,497 | 15,471 | 28,549 |
| General and administrative expenses | 3,131 | 16,716 | (553) | 23,193 |
| Total operating expenses | 24,347 | 79,091 | 89,275 | 212,336 |
| Gain (Loss) from operations | 92,163 | (324,579) | 27,235 | (371,309) |
| Other expense: | ||||
| Net operating gain (loss) | $ 29,417 | $ (383,912) | $ (214,756) | $ (599,302) |
| Basic gain (loss) per share | ||||
| Net operating loss per share (in dollars per share) | $ 0.01 | $ (0.14) | $ (0.08) | $ (0.22) |
| Weighted average shares outstanding (in shares) | 2,726,955 | 2,726,955 | 2,726,955 | 2,726,955 |
| Nonrelated Party [Member] | ||||
| Other expense: | ||||
| Interest expense | $ (62,746) | $ (59,333) | $ (241,991) | $ (227,994) |
| Related Party [Member] | ||||
| Other expense: | ||||
| Interest expense | $ 0 | $ 0 | $ 0 | $ 0 |
| X | ||||||||||
- Definition The aggregate total of expenses (income) of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. No definition available.
|
| X | ||||||||||
- Definition A fee, net of any income, charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. No definition available.
|
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of realized gain (loss) on investment in debt and equity securities. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of unrealized gain (loss) on investment in debt and equity securities. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense for debt. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of dividend income on nonoperating securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|